Biotech

All Articles

Atea's COVID antiviral fails to stop hospital stays in period 3

.Atea Pharmaceuticals' antiviral has actually stopped working an additional COVID-19 trial, but the ...

Neurocrine's bid to spare mental illness prospect fails

.Neurocrine Biosciences' schizophrenia program pivot has failed. The biotech was actually not able t...

Sanofi spends $110M upfront for late-stage radioligand therapy

.Sanofi has actually created a late entrance to the radioligand gathering, paying out one hundred th...

F 2G brings up $100M for 2nd effort to acquire brand-new antifungal to market

.After F2G's first try to receive a new lesson of antifungal to market was actually wrecked by the F...

Moderna targets $1.1 B in R&ampD spending slices, drops 5 plans amid profits tensions

.Moderna has actually sworn to cut R&ampD spending through $1.1 billion by 2027. The selection to sh...

Sanofi's $80M bet on Fulcrum dystrophy medicine ends in period 3 crash

.Just 4 months after Sanofi bet $80 million in beforehand cash money on Key Therapies' losmapimod, t...

Oncternal stock sinks 60% amidst layoffs, trial terminations

.Cancer cells business Oncternal Therapeutics is actually folding all its scientific tests and layin...

Roche is actually keeping out chances that its injectable being overweight possibility can eventually demonstrate 25% weight-loss in late-stage trial

.Roche is actually storing out hopes that its injectable weight problems possibility could inevitabl...

Novo Nordisk hails 'exceptional' weight reduction result for dual-acting dental drug in very early test

.Novo Nordisk has actually raised the lid on a phase 1 test of its dental amylin as well as GLP-1 re...

AbbVie files a claim against BeiGene over blood cancer cells medication trade secrets

.Only a few quick full weeks after succeeding an FDA Fast lane tag for its investigational BTK degra...